Opus Genetics, Inc

IRDNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

82.6M

on 2026-06-30, from 25.1M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$300.0M

S-3 of 2026-08-07. Sales under the at-the-market programme filed with it are not stated apart. S-3 ↗

$125.0M

Leerink Partners, agreement of 2026-08-06. No at-the-market sales statement read from a 10-Q or 10-K. S-3 ↗

Warrants

19.62M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

8.7 quarters

$88.8M on 2026-06-30 ÷ $10.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-02-13	Private placement	7,374,632	$3.39	$25.0M	8-K ↗

Also on file: $35.0M senior secured notes, 2026-04-02 8-K ↗ · $35.0M senior secured notes, 2026-04-21 8-K ↗